ERBB2 and breast carcinoma: Different to primary breast cancers metabolomics has shown distinct traits in correlation with histopathology, higher expression of Her2 [35], [36], [37] and microenvironment composition [38], [39], much less is known about the metabolomic profile of mBC lesions.